These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6803282)

  • 1. High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.
    Raisman R; Sechter D; Briley MS; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1981; 75(4):368-71. PubMed ID: 6803282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 3H-imipramine binding: a state-dependent marker in depression.
    Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls.
    Wägner A; Aberg-Wistedt A; Asberg M; Ekqvist B; Mårtensson B; Montero D
    Psychiatry Res; 1985 Oct; 16(2):131-9. PubMed ID: 3865253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
    Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
    Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity 3H-imipramine binding in platelets of children and adolescents with major affective disorders.
    Rehavi M; Weizman R; Carel C; Apter A; Tyano S
    Psychiatry Res; 1984 Sep; 13(1):31-9. PubMed ID: 6595683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in human platelet 3H-imipramine binding.
    Tang SW; Morris JM
    Psychiatry Res; 1985 Oct; 16(2):141-6. PubMed ID: 3865254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity 3H-imipramine binding: a new biological marker in depression.
    Langer SZ; Zarifian E; Briley M; Raisman R; Sechter D
    Pharmacopsychiatria; 1982 Jan; 15(1):4-10. PubMed ID: 7038720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-imipramine platelet binding sites in unipolar depression.
    Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
    Biol Psychiatry; 1983 Dec; 18(12):1403-9. PubMed ID: 6661469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
    Arora RC; Meltzer HY
    Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of yohimbine and imipramine to platelets in depressive illness.
    Braddock L; Cowen PJ; Elliott JM; Fraser S; Stump K
    Psychol Med; 1986 Nov; 16(4):765-73. PubMed ID: 3029789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal variation in platelet 3H-imipramine binding: comparable values in control and depressed populations.
    Whitaker PM; Warsh JJ; Stancer HC; Persad E; Vint CK
    Psychiatry Res; 1984 Feb; 11(2):127-31. PubMed ID: 6584935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
    Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
    Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.
    Suranyi-Cadotte BE; Quirion R; Nair NP; Lafaille F; Schwartz G
    Life Sci; 1985 Feb; 36(8):795-9. PubMed ID: 3974410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.